This report provides an analysis of the global synthetic drugs market and includes both Amphetamine-Type Stimulants (ATS) and New Psychoactive Substances (NPS).
These briefings offer evidence of the ineffectiveness of the traditional “war on drugs” approach to reduce the supply or demand for drugs in consumer markets, and provide policy guidance and examples of best practice on new drug law strategies.
This report explores the use of supply-side policies, including eradication strategies to reduce the supply of drugs and their varied effects and results on US counter-narcotics efforts.
